Unknown

Dataset Information

0

Low Hydrophobic Mismatch Scores Calculated for HLA-A/B/DR/DQ Loci Improve Kidney Allograft Survival.


ABSTRACT: We evaluated the impact of human leukocyte antigen (HLA) disparity (immunogenicity; IM) on long-term kidney allograft survival. The IM was quantified based on physicochemical properties of the polymorphic linear donor/recipient HLA amino acids (the Cambridge algorithm) as a hydrophobic, electrostatic, amino acid mismatch scores (HMS\AMS\EMS) or eplet mismatch (EpMM) load. High-resolution HLA-A/B/DRB1/DQB1 types were imputed to calculate HMS for primary/re-transplant recipients of deceased donor transplants. The multiple Cox regression showed the association of HMS with graft survival and other confounders. The HMS integer 0-10 scale showed the most survival benefit between HMS 0 and 3. The Kaplan-Meier analysis showed that: the HMS=0 group had 18.1-year median graft survival, a 5-year benefit over HMS>0 group; HMS ? 3.0 had 16.7-year graft survival, a 3.8-year better than HMS>3.0 group; and, HMS ? 7.8 had 14.3-year grafts survival, a 1.8-year improvement over HMS>7.8 group. Stratification based on EMS, AMS or EpMM produced similar results. Additionally, the importance of HLA-DR with/without -DQ IM for graft survival was shown. In our simulation of 1,000 random donor/recipient pairs, 75% with HMS>3.0 were re-matched into HMS ? 3.0 and the remaining 25% into HMS?7.8: after re-matching, the 13.5 years graft survival would increase to 16.3 years. This approach matches donors to recipients with low/medium IM donors thus preventing transplants with high IM donors.

SUBMITTER: Bekbolsynov D 

PROVIDER: S-EPMC7659444 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications


We evaluated the impact of human leukocyte antigen (HLA) disparity (immunogenicity; IM) on long-term kidney allograft survival. The IM was quantified based on physicochemical properties of the polymorphic linear donor/recipient HLA amino acids (the Cambridge algorithm) as a hydrophobic, electrostatic, amino acid mismatch scores (HMS\AMS\EMS) or eplet mismatch (EpMM) load. High-resolution HLA-A/B/DRB1/DQB1 types were imputed to calculate HMS for primary/re-transplant recipients of deceased donor  ...[more]

Similar Datasets

| S-EPMC6563434 | biostudies-literature
| S-EPMC2998531 | biostudies-literature
| S-EPMC3003381 | biostudies-literature
| S-EPMC6058777 | biostudies-literature
| S-EPMC2527859 | biostudies-literature
| S-EPMC5316504 | biostudies-literature
| S-EPMC2824608 | biostudies-literature
| S-EPMC5777204 | biostudies-literature
| S-EPMC3110277 | biostudies-literature
| S-EPMC3165112 | biostudies-literature